Artificial Intelligence

AMC Robotics establishes a new manufacturing hub in Ho Chi Minh City, a strategic move to scale its Kyro robot and join the global tech shift to Vietnam.

With promising 3-year vision data and a manufacturing breakthrough, Lineage is pioneering 'off-the-shelf' cell therapies for blindness, diabetes, and more.

With pivotal Phase 2 data for its non-invasive skin cancer patch due in Q1, Medicus Pharma is advancing a diverse pipeline fueled by AI and strategic acquisitions.

A landmark $1.2M order for its advanced LineaDNA validates the firm's biotech arm, but can scientific success balance its new, volatile crypto strategy?

Formerly Cybin, Helus Pharma's Nasdaq launch marks a pivotal shift towards commercializing its breakthrough depression and anxiety drug pipeline.

A new 10,000-sample 'skin library' collected by painless stickers aims to slash drug development time and costs for biopharmaceutical partners.

Acorn Energy partners with AIO Systems to bring AI-driven monitoring to cell towers and data centers, targeting a market projected to exceed $13 billion.

Gyre Therapeutics secures a pivotal conditional approval pathway in China for its novel liver fibrosis drug, offering hope for millions of hepatitis B patients.

A new partnership aims to unlock the potential of a next-gen obesity drug by pairing it with advanced delivery tech to overcome historical hurdles.

AE Industrial acquires L3Harris's propulsion unit, reviving the iconic Rocketdyne name to modernize legacy engines and pioneer nuclear power for deep space.

As MRAM demand surges in critical sectors, Everspin Technologies prepares to detail its financial health and strategic roadmap at a key investor event.

With a key drug decision looming and a refocused strategy, Rocket Pharmaceuticals faces a critical audience at the J.P. Morgan Healthcare Conference.

With its blockbuster drug's patent cliff looming, Merck's leadership faces high stakes at the JPM conference to unveil its strategy for future growth.

COOLFLY debuts its Aura Smart Bird Feeder at CES 2026, blending high-end design, a modular camera, and a 'Bird-tok' social community.

Facing its lowest donation levels in two decades, the Red Cross offers a Super Bowl trip to spur giving as hospitals risk rationing critical blood supplies.

Sanofi is investing up to $2.56 billion in Earendil Labs' AI platform to discover next-gen bispecific antibodies for complex autoimmune diseases.

With Clay Van Doren as new CEO, Avenga signals a major push for global leadership in AI and digital engineering, leveraging his Atos experience.

Kodiak AI partners with automotive giant Bosch to scale autonomous truck hardware, a landmark deal set to accelerate the driverless freight revolution.

Fresh off a massive 240% revenue surge, Nutex Health prepares to showcase its micro-hospital model and physician-led strategy to top global investors.

The electric vehicle maker is diversifying into the high-stakes world of AI, partnering with a top university to develop quadruped security robots.